Advances in engineering homing endonucleases for gene targeting: Ten years after structures

Autologous And Cancer Stem Cell Gene Therapy

Volumn , Issue , 2007, Pages 135-167

  Stoddard, Barry L ^a   Scharenberg, Andrew M ^b,c   Monnat, Raymond J ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

DNA recognition; Gene correction; Gene therapy; Genome engineering; Homing endonuclease; LAGLIDADG; recombination; Protein engineering

Indexed keywords

EID: 85115913704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812775870_0006     Document Type: Chapter

References (101)

1. Abbott A. (2006) Questions linger about unexplained gene-therapy trial death. Nat Med 12: 597.
2. Agaard C, Awayez MJ, Garrett RA. (1997) Profile of the DNArecognition site of the archaeal homing endonuclease I-DmoI. Nucl Acids Res 25:1523-30.
3. Arnould S, Chames P, Perez C, et al. (2006) Engineering of large numbers of highly specific homing endonucleases that induce recombination on novelDNAtargets. J Mol Biol 355: 443-58.
4. Arnould S, Perez C, Cabaniols J-P, et al. (2007) Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells. J Mol Biol 371: 49-65.
5. Ashworth J, Havranek JJ, Duarte CM, et al. (2006) Computational redesign of endonuclease DNAbinding and cleavage specificity. Nature 441: 656-59.
6. Baird PA, Anderson TW, Newcombe HB, Lowry RB. (1988) Genetic disorders in children and young adults: a population study. Am J Hum Genet 42: 677-93.
7. Baum C. (2007) Fourth case of leukaemia in the first SCID-X1 gene therapy trial, and the diversity of gene therapy. http://www.esgct.org/upload/4th_CaseofLeukemial.pdf
8. Beerli RR, Barbas CF. (2002) Engineering polydactyl zinc-finger transcription factors. Nat Biotechnol 20: 130-41.
9. Belfort M, Reaban ME, Coetzee T, Dalgaard JZ. (1995) Prokaryotic introns and inteins: a panoply of form and function. J Bacter 177: 3897-903.
10. Belfort M, Roberts RJ. (1997) Homing endonucleases-keeping the house in order. Nucl Acids Res 25: 3379-88.
11. Bertolotti R. (1996) Recombinase-mediated gene therapy: strategies based on Lesch-Nyhan mutants for gene repair/inactivation using human RAD51 nucleoprotein filaments. Biogenic Amines 12: 487-98.
12. Bibikova M, Beumer K, Trautman JK, Carroll D. (2003) Enhancing gene targeting with designed zinc finger nucleases. Science 300: 764.
13. Bibikova M, Carroll D, Segal DJ, et al. (2001) Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21: 289-97.
14. Bolduc JM, Spiegel PC, Chatterjee P, et al. (2003) Structural and biochemical analyses of DNA and RNA binding by a bifunctional homing endonuclease and group I intron splicing cofator. Genes Dev 17: 2875-88.
15. Bullard DC, Weaver CT. (2002) Cutting-edge technology: IV. Genomic engineering for studies of the gastrointestinal tract in mice. Am J Physiol Gastrointest Liver Physiol 283: G1232-37.
16. Bulyk ML, Huang XH, Choo Y, Church GM. (2001) Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci USA 98: 7158-63.
17. Burt A. (2003) Site-specific selfish genes as tools for the control and genetic engineering of natural populations. Proc R Soc Lond B Biol Sci 270: 921-28.
18. Burt A. (2005) Gates Grand Challenge Project. In: Homing Endonuclease Genes: New Tools for Mosquito Population Engineering and Control. www.gcgh.org.
19. Chames P, Epinat JC, Guillier S, et al. (2005) In vivo selection of engineered homing endonucleases using double-strand break induced homologous recombination. Nucl Acids Res 33: e178.
20. Chase CD. (2006) Genetically engineered cytoplasmic male sterility. Trends Plant Sci 11: 7-9.
21. Chevalier B, Sussman D, Otis C, et al. (2004) Analysis of the symmetric metaldependent I-CreI homing endonuclease mechanism. Biochemistry 43: 4015-26.
22. Chevalier B, Turmel M, Lemieux C, et al. (2003) FlexibleDNAtarget site recognition by divergent homing endonuclease isoschizomers I-CreI and I-MsoI. J Mol Biol 329: 253-69.
23. Chevalier BS, Kortemme T, Chadsey MS, et al. (2002) Design, activity and structure of a highly specific artificial endonuclease. Mol Cell 10: 895-905.
24. Chevalier BS, Monnat RJ Jr, Stoddard BL. (2001) The homing endonuclease I-CreI uses three metals, one of which is shared between the two active sites. Nat Struct Biol 8: 312-16.
25. Chevalier BS, Stoddard BL. (2001) Homingendonucleases: structural and functional insight into the catalysts of intron/intein mobility. Nucl Acids Res 29: 3757-74.
26. Christianson A, Howson CP, Modell B. (2006) Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. March of Dimes, White Plains, New York.
27. Coates CJ, Kaminski JM, Summers JB, et al. (2005) Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools. Trends Biotechnol 23: 407-19.
28. Colleaux L, D’Auriol L, Betermier M, et al. (1986) Universal code equivalent of a yeast mitochondrial intron reading frame is expressed into E. coli as a specific double strand endonuclease. Cell 44: 521-33.
29. Colleaux L, D’Auriol L, Galibert F, Dujon B. (1988) Recognition and cleavage site of the intron-encoded omega transposase. Proc Natl Acad Sci USA 85: 6022-26.
30. Dalgaard JZ, Garrett RA, Belfort M. (1994) Purification and characterization of two forms of I-DmoI, a thermophilic site-specific endonuclease encoded by an archaeal intron. J Biol Chem 269: 28885-92.
31. Dalgaard JZ, Klar AJ, Moser MJ, et al. (1997) Statistical modeling and analysis of the LAGLIDADG family of site-specific endonucleases and identification of an intein that encodes a site-specific endonuclease of the HNH family. Nucl Acids Res 25: 4626-38.
32. Delahodde A, Goguel V, Becam AM, et al. (1989) Site-specific DNA endonuclease and RNA maturase activities of two homologous intron-encoded proteins from yeast mitochondria. Cell 56: 431-41.
33. Doetschman T, Gregg RG, Maeda N, et al. (1987) Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330: 576-78.
34. Doyon JB, Pattanayak V, Meyer CB, Liu DR. (2006) Directed evolution and substrate specificity profile of homing endonuclease I-SceI. J Am Chem Soc 128: 2477-84.
35. Duan X, Gimble FS, Quiocho FA. (1997) Crystal structure of PI-SceI, a homing endonuclease with protein splicing activity. Cell 89: 555-64.
36. Dujon B. (1980) Sequence of the intron and flanking exons of the mitochondrial 21S rRNA gene of yeast strains having different alleles at the omega and rib-1 loci. Cell 20: 185-97.
37. Dujon B. (1989) Group I introns as mobile genetic elements: facts and mechanistic speculations - a review. Gene 82: 91-114.
38. Dujon B, Belfort M, Butow RA, et al. (1989) Mobile introns: definition of terms and recommended nomenclature. Gene 82: 115-18.
39. Durrenberger F, Rochaix J-D. (1993) Characterization of the cleavage site and the recognition sequence of the I-CreI DNAendonuclease encoded by the chloroplast ribosomal intron of Chlamydomonas reinhardtii. Mol Gen Genet 236: 409-14.
40. Epinat JC, Arnould S, Chames P, et al. (2003) A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells. Nucl Acids Res 31: 2952-62.
41. Fitzsimons-Hall M, Noren CJ, Perler FB, Schildkraut I. (2002) Creation of an artificial bifunctional intein by grafting a homing endonuclease into a mini-intein. J Mol Biol 323: 173-79.
42. Geese WJ, Waring RB. (2001) A comprehensive characterization of a group IB intron and its encoded maturase reveals that protein-assisted splicing requires an almost intact intron RNA. J Mol Biol 308: 609-22.
43. Ghatge M, Palaniappan N, Das Choudhuri S, Reynolds K. (2006) Genetic manipulation of the biosynthetic process leading to phoslactomycins, potent protein phosphatase 2A inhibitors. J Ind Microbiol Biotechnol 33: 589-99.
44. Gimble FS, Moure CM, Posey KL. (2003) Assessing the plasticity of DNAtarget site recognition of the PI-SceI homing endonuclease using a bacterial two-hybrid selection system. J Mol Biol 334: 993-1008.
45. Glaser S, Anastassiadis K, Stewart AF. (2005) Current issues in mouse genome engineering. Nat Genet 37: 1187-93.
46. Gouble A, Smith J, Bruneau S, et al. (2006) Efficient in toto targeted recombination in mouse liver by meganuclease-induced double-strand break. J Gene Med 8: 616-22.
47. Griesenbach U, Geddes DM, Alton EW. (2006) Gene therapy progress and prospects: cystic fibrosis. Gene Ther 13: 1061-67.
48. Gruen M, Chang K, Serbanescu I, Liu DR. (2002) An in vivo selection system for homing endonuclease activity. Nucl Acids Res 30: 29-34.
49. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-19.
50. Heath PJ, Stephens KM, Monnat RJ, Stoddard BL. (1997) The structure of I-Cre
51. Hinnen A, Hicks JB, Fink GR. (1978) Transformation of yeast. Proc Natl Acad Sci USA 75: 1929-33.
52. Jacquier A, Dujon B. (1985) An intron-encoded protein is active in a gene conversion process that spreads an intron into a mitochondrial gene. Cell 41: 383-94.
53. Jin Y, Binkowski G, Simon LD, Norris D. (1997) Ho endonuclease cleaves MAT DNA in vitro by an inefficient stoichiometric reaction mechanism. J Biol Chem 272: 7352-59.
54. Jurica MS, Monnat RJ Jr, Stoddard BL. (1998) DNArecognition and cleavage by the LAGLIDADG homing endonuclease I- CreI. Mol Cell 2: 469-76.
55. Kolb AF, Coates CJ, Kaminski JM, et al. (2005) Site-directed genome modification: nucleic acid and protein modules for targeted integration and gene correction. Trends Biotechnol 23: 399-406.
56. Koller BH, Smithies O. (1989) Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 86: 8932-35.
57. Kostriken R, Strathern JN, Klar AJ, et al. (1983) Asite-specific endonuclease essential for mating-type switching in Saccharomyces cerevisiae. Cell 35: 167-74.
58. Lavery R. (2005) Recognizing DNA. Q Rev Biophys 38: 339-44.
59. Lazowska J, Claisse M, Gargouri A, et al. (1989) Protein encoded by the third intron of cytochrome b gene in Saccharomyces cerevisiae is an mRNAmaturase. Analysis of mitochondrial mutants, RNA transcripts proteins and evolutionary relationships. J Mol Biol 205: 275-89.
60. Lazowska J, Jacq C, Slonimski PP. (1980) Sequence of introns and flanking exons in wild-type and box3 mutants of cytochrome b reveals an interlaced splicing protein coded by an intron. Cell 22: 333-48.
61. Malik P, Arumugam PI. (2005) Gene therapy for {beta}-thalassemia. Hematol Am Soc Hematol Educ Program: 45-50.
62. Malik P, Arumugam PI, Yee JK, Puthenveetil G. (2005) Successful correction of the human Cooley’s anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator. Ann N Y Acad Sci 1054: 238-49.
63. McCandless SE, Brunger JW, Cassidy SB. (2004) The burden of genetic disease on inpatient care in a children’s hospital. Am J Hum Genet 74: 121-27.
64. Moure C, Gimble F, Quiocho F. (2002) Crystal structure of the intein homing endonuclease PI-SceI bound to its recognition sequence. Nat Struct Biol 9: 764-70.
65. Moure CM, Gimble FS, Quiocho FA. (2003) The crystal structure of the gene targeting homing endonuclease I-SceI reveals the origins of its target site specificity. J Mol Biol 334: 685-96.
66. Orr-Weaver TL, Szostak JW, Rothstein RJ. (1981) Yeast transformation: a model system for the study of recombination. Proc Natl Acad Sci USA 78: 6354-58.
67. Pabo CO, Nekludova L. (2000) Geometric analysis and comparison of protein-DNA interfaces: Why is there no simple code for recognition? J Mol Biol 301: 597-624.
68. Pâques F, Duchateau P. (2007) Meganucleases and DNA double-strand breakinduced recombination: perspectives for gene therapy. Curr Gene Ther 7: 49-66.
69. Perrin A, Buckle M, Dujon B. (1993) Asymmetrical recognition and activity of the I-SceI endonuclease on its site and on intron-exon junctions. EMBOJ 12: 2939-47.
70. Porteus MH. (2006) Mammalian gene targeting with designed zinc finger nucleases. Mol Ther 13: 438-46.
71. Porteus MH, Baltimore D. (2003) Chimeric nucleases stimulate gene targeting in human cells. Science 300: 763.
72. Posfai G, Kolisnychenko V, Bereczki Z, Blattner FR. (1999) Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome. Nucl Acids Res 27: 4409-15.
73. Puthenveetil G, Scholes J, Carbonell D, et al. (2004) Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood 104: 3445-53.
74. Rosen LE, Morrison HA, Masri S, et al. (2006) Homing endonuclease I-CreI derivatives with novel DNAtarget specificities. Nucl Acids Res 34: 4791-800.
75. Sadelain M. (2006) Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia. Curr Opin Hematol 13: 142-48.
76. Samakoglu S, Lisowski L, Budak-Alpdogan T, et al. (2006) A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol 24: 89-94.
77. Scalley-Kim M, McConnell-Smith A, Stoddard BL. (2007) Coevolution of a homing endonuclease and its host target sequence. J Mol Biol, in press.
78. Schafer B, Wilde B, Massardo DR, et al. (1994) A mitochondrial group-I intron in fission yeast encodes a maturase and is mobile in crosses. Curr Genet 25: 336-41.
79. Segal DJ, Beerli RR, Blancafort P, et al. (2003) Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteins. Biochemistry 42: 2137-48.
80. Segal DJ, Dreier B, Beerli RR, Barbas CF. (1999) Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5'-GNN-3' DNAtarget sequences. Proc Natl Acad Sci USA 96: 2758-63.
81. Seligman L, Chisholm KM, Chevalier BS, et al. (2002) Mutations altering the cleavage specificity of a homing endonuclease. Nucl Acids Res 30: 3870-79.
82. Silva GH, Belfort M. (2004) Analysis of theLAGLIDADGinterface of the monomeric homing endonuclease I-DmoI. Nucl Acids Res 32: 3156-68.
83. Silva GH, Belfort M, Wende W, Pingoud A. (2006) From monomeric to homodimeric endonucleases and back: engineering novel specificity of LAGLIDADG enzymes. J Mol Biol 361: 744-54.
84. Sitbon E, Pietrokovski S. (2003) Newtypes of conserved sequence domains in DNAbinding regions of homing endonucleases. Trends Biochem Sci 28: 473-77.
85. Smith J, Bibikova M, Whitby FG, et al. (2000) Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucl Acids Res 28: 3361-69.
86. Smith J, Grizot S, Arnould S, et al. (2006) Acombinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucl Acids Res 34: e149.
87. Spiegel PC, Chevalier B, Sussman D, et al. (2006) The structure of I-CeuI homing endonuclease: evolving asymmetric DNArecognition from a symmetric protein scaffold. Structure 14: 869-80.
88. Steuer S, Pingoud V, Pingoud A, Wende W. (2004) Chimeras of the homing endonuclease PI-SceI and the homologous Candida tropicalis intein: a study to explore the possibility of exchanging DNA-binding modules to obtain highly speciric endonucleases with altered specificity. Chembiochem 5: 206-13.
89. Stoddard BL. (2005) Homing endonuclease structure and function. Q Rev Biophys 38: 49-95.
90. Sussman DJ, Chadsey M, Fauce S, et al. (2004) Isolation and characterization of new homing endonuclease specificities at individual target site positions. J Mol Biol 342: 31-41.
91. Themis M, Waddington SN, Schmidt M, et al. (2005) Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 12: 763-71.
92. Thompson AJ, Yuan X, Kudlicki W, Herrin DL. (1992) Cleavage and recognition pattern of a double-strand-specific endonuclease (I-CreI) encoded by the chloroplast 23S rRNA intron of Chlamydomonas reinhardtii. Gene 119: 247-51.
93. Thrasher AJ, Gaspar HB, Baum C, et al. (2006) Gene therapy: X-SCID transgene leukaemogenicity. Nature 443: E5-E6; discussion E6-E7.
94. Tzfira T, White C. (2005) Towards targeted mutagenesis and gene replacement in plants. Trends Biotechnol 23: 567-69.
95. Urnov FD, Miller JC, Lee YL, et al. (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435: 646-51.
96. Vasquez KM, Marburger K, Intody Z, Wilson JH. (2001) Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci USA 98: 8403-10.
97. Volna P, Jarjour J, Baxter S, et al. (2007) Flow cytometric analysis of DNA binding and cleavage by cell surface-displayed homing endonucleases. Nucl Acids Res 35: 2748-58.
98. Wang L, Jackson WC, Steinbach PA, Tsien RY. (2004) Evolution of new nonantibody proteins via iterative somatic hypermutation. Proc Natl Acad Sci USA 101: 16745-49.
99. Wintjens R, Rooman M. (1996) Structural classification of HTH DNA-binding domains and protein-DNA interaction modes. J Mol Biol 262: 294-313.
100. Wolfe SA, Nekludova L, Pabo CO. (2000a) DNArecognition by Cys2His2 zinc finger proteins. Ann Rev Biophys Biomol Struct 29: 183-212.
101. Wolfe SA, Ramm EI, Pabo CO. (2000b) Combining structure-based design with phage display to create new Cys2His2 zinc finger dimers. Structure 8: 739-50.